• The New Penicillin? Pharmacotherapy for Obesity

  • Nov 19 2024
  • Duración: 26 m
  • Podcast

The New Penicillin? Pharmacotherapy for Obesity

  • Resumen

  • Join Drs Nihar Desai and Neda Rasouli as they discuss the evolution of obesity treatment over the past two decades, including the latest novel therapies.

    Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999845. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A State-of-the-Art Review https://pubmed.ncbi.nlm.nih.gov/38103820/

    Obesity https://emedicine.medscape.com/article/123702-overview

    A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association https://pubmed.ncbi.nlm.nih.gov/37807920/

    Obesity and Severe Obesity Prevalence in Adults: United States, August 2021–August 2023 https://www.cdc.gov/nchs/products/databriefs/db508.htm

    Physiology, Obesity Neurohormonal Appetite and Satiety Control https://www.ncbi.nlm.nih.gov/books/NBK555906/

    Melanocortin-4 Receptor Complexity in Energy Homeostasis, Obesity and Drug Development Strategies https://pubmed.ncbi.nlm.nih.gov/34882941/

    Bariatric Surgery https://emedicine.medscape.com/article/197081-overview

    The Effects of Bariatric Surgery on Cardiovascular Outcomes and Cardiovascular Mortality: A Systematic Review and Meta-Analysis https://pubmed.ncbi.nlm.nih.gov/36909063/

    Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes https://pubmed.ncbi.nlm.nih.gov/37952131/

    Comparison of Tirzepatide and Dulaglutide on Major Adverse Cardiovascular Events in Participants With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: SURPASS-CVOT Design and Baseline Characteristics https://pubmed.ncbi.nlm.nih.gov/37758044/

    A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO) https://clinicaltrials.gov/study/NCT05556512

    Effects of Semaglutide on Chronic Kidney Disease in Patients With Type 2 Diabetes https://pubmed.ncbi.nlm.nih.gov/38785209/

    Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre The New Penicillin? Pharmacotherapy for Obesity

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.